CMS’ addition of more than 560 codes to the ASC covered procedure list for 2026 has sparked new engagement from ASC leaders interested in expanding service lines, especially for cardiovascular and ...

At the 10th Annual Orthopedic, Spine & Pain Management-Driven ASC Conference in Chicago, Mark Coleman, MD, senior partner of National Spine and Pain Centers gave a presentation titled “Evolving ...

Epidural anesthetic or steroid injections, nerve blocks, and related interventions are commonly used to treat chronic back pain. This review found no solid evidence showing that these interventions ...

FORT LAUDERDALE, Fla., May 21, 2025 /PRNewswire/ -- In a landmark publication featured ahead of print in The Spine Journal, Dr. Kingsley R. Chin—board-certified orthopedic spine surgeon, professor, ...

LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global interventional spine devices market is expected to grow at a CAGR of more than 10% during the forecast ...

Orthopaedic & Spine Center or the Rockies in Longmont When it comes to our current healthcare system, jumping through hoops is much more of a rule than an exception. Enter the Comprehensive Spine Team ...

In 2022, Brain and Spine Surgeons of New York (BSSNY) will be opening three new “office-based surgery” OBS Suites in White Plains to perform pain management procedures such as Ketamine Infusions or ...

LONDON--(BUSINESS WIRE)--Technavio has announced the top five leading vendors in their recent interventional spine devices market in the US report. This research report also lists 20 other prominent ...

Conscious sedation for spine procedures in the ambulatory setting is associated with a low rate of adverse events comparable to local anesthesia without conscious sedation, according to a Doctor’s ...

KALAMAZOO (WWJ) --Stryker Interventional Spine announced the clearance of 510(k)s, United States Food and Drug Administration approval allowing the sale of two additional products in its portfolio.

In a new practice advisory, an international team of experts discussed the use of gadolinium-based contrast agents (GBCAs), an alternative to iodinated contrast media, in interventional pain ...